These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30771682)

  • 1. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.
    Schlichtemeier SM; Nahm CB; Xue A; Gill AJ; Smith RC; Hugh TJ
    J Surg Res; 2019 Jun; 238():127-136. PubMed ID: 30771682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
    Schlichtemeier SM; Pang TC; Williams NE; Gill AJ; Smith RC; Samra JS; Lam VW; Hollands M; Richardson AJ; Pleass HC; Nozawa S; Albania M; Hugh TJ
    Eur J Surg Oncol; 2016 Oct; 42(10):1576-83. PubMed ID: 27378158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
    Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
    Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
    Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
    Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
    World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.
    Cao XL; Li H; Yu XL; Liang P; Dong BW; Fan J; Li M; Liu FY
    PLoS One; 2013; 8(12):e82448. PubMed ID: 24349287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
    Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
    Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
    Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
    HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
    Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
    J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
    Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
    BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors.
    Li SH; Wei W; Guo RP; Shi M; Guo ZX; Chen ZY; Xiao CZ; Cai MY; Zheng L
    Med Oncol; 2013 Dec; 30(4):696. PubMed ID: 23975633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.